These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Mutations of neuraminidase implicated in neuraminidase inhibitors resistance. Ferraris O; Lina B J Clin Virol; 2008 Jan; 41(1):13-9. PubMed ID: 18055254 [TBL] [Abstract][Full Text] [Related]
34. [In vitro antiviral activity of antisense oligonucleotides against influenza virus]. Chen Z; Wang S; Guan W; Yang B; Sun Z Wei Sheng Wu Xue Bao; 2000 Oct; 40(5):482-7. PubMed ID: 12548758 [TBL] [Abstract][Full Text] [Related]
35. Regulatory perspective in the United States on cell cultures for production of inactivated influenza virus vaccines. Levandowski RA Dev Biol Stand; 1999; 98():171-5; discussion 197. PubMed ID: 10494970 [TBL] [Abstract][Full Text] [Related]
36. Antiviral effects of rhIFN-alpha 1 against seven influenza viruses. Li F; Wang QJ; Zhu BL; Wang M Zhongguo Yao Li Xue Bao; 1999 Aug; 20(8):709-14. PubMed ID: 10678103 [TBL] [Abstract][Full Text] [Related]
37. [Effect of L-lysine-a-oxidase on reproduction of herpes simplex type I virus in vitro]. Smirnova IP; Diorditsa SV; Alekseev SB; Zaĭtsev IZ Vopr Med Khim; 1998; 44(4):384-7. PubMed ID: 9845927 [TBL] [Abstract][Full Text] [Related]
38. Chitosan as an adjuvant for parenterally administered inactivated influenza vaccines. Ghendon Y; Markushin S; Krivtsov G; Akopova I Arch Virol; 2008; 153(5):831-7. PubMed ID: 18297235 [TBL] [Abstract][Full Text] [Related]
39. [Variability of the sensitivity of human lymphocytes to the antiproliferative action of alkylating agents]. Veremko LN; Telegin LIu; Pevnitskii LA Biull Eksp Biol Med; 1983 May; 95(5):73-5. PubMed ID: 6405824 [TBL] [Abstract][Full Text] [Related]